Synvia was founded in 2005 as CAEP – Advanced Center for Studies and Research. Today, we conduct over 200 pharmaceutical bioequivalence studies annually and have built deep expertise in developing and validating bioanalytical methods.
With a track record of high-impact projects, we are committed to delivering top‐quality services and offering strategic support to our sponsors.
We conduct harmonized bioequivalence studies under international guidelines, ensuring our results are consistent and accepted by regulatory agencies across Latin America.
We have extensive experience conducting studies for submission to the European Medicines Agency (EMA), ensuring full regulatory compliance and adherence to the highest standards.
Dedicated unit for participant recruitment (screening), with the capacity for more than 5,000 screenings per month.
Intensive observation rooms equipped with ambulatory cardiac monitoring and access to emergency care.
Specialized medical team with 24-hour assistance throughout the study period.
Integrated system for data management and electronic data capture during trials.
Safe, temperature-controlled area for medication storage.
162 beds in 4 wards with varied layouts to simultaneously accommodate different types of studies.
Dozens of Ultrafreezers and Freezers for different temperatures equipped with alarm and monitoring systems to ensure the safe storage of biological samples.
We have a highly qualified technical team, including master’s and Ph.D. experts in method development and validation.
Developed and validated bioanalytical methods.
Analytical capacity exceeding 100,000 samples per month.
O maior Parque Analítico da América Latina. Nossas instalações modernas incluem equipamentos de ponta, como:
The largest analytical park in Latin America. Our state-of-the-art facilities include cutting-edge equipment, such as:
Detailed assessment, including technical discussions and expertise exchange.
Real-time tracking to ensure transparency and compliance with deadlines.
Optimized recruitment through multiple channels and artificial intelligence.
Targeted strategies to effectively attract new participants.
Efficient importation of supplies and standards.
Preparation of precise and detailed analyses and reports.
A robust system aligned with the highest regulatory standards, including internal audits and external inspections.
Talk to a commercial consultant:
Join us and help make medical treatments accessible to millions of Brazilians.
